Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perillyl Alcohol in Metastatic Androgen Independent Prostate Cancer
NCT00003238Phase 2Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Feb 1998
- Primary completion
- Oct 2001
- Modality
- Nucleic Acid-Directed Small Molecules, Inhalation Devices, Covalent Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of NEO100-02 in prostate cancer (PCa), sponsored by University of Wisconsin–Madison. Started Feb 1998; status: completed.
02
Drugs
NEO100-02
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00003238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003238.